Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

REVOLUTION MEDICINES INC (RVMD)

384 + Investors. Track Smart Money conviction in RVMD. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +62
Streak
10Q ▲
Buyers last Q
61%

Smart Money Signals — RVMD

Based on 368 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 10 quarters in a row

last 6Q
For 10 consecutive quarters, more hedge funds added RVMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
368 hedge funds hold RVMD right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +39% more funds vs a year ago

fund count last 6Q
+104 new funds entered over the past year (+39% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 61% buying

231 buying145 selling
Last quarter: 231 funds were net buyers (102 opened a brand new position + 129 added to an existing one). Only 145 were sellers (105 trimmed + 40 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+40 vs last Q)

new funds entering per quarter
Funds opening a new RVMD position: 48 → 56 → 62 → 102. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 37% long-term, 33% new

■ 37% conviction (2yr+) ■ 30% medium ■ 33% new
Of the 368 current holders: 136 (37%) held >2 years, 111 held 1–2 years, and 121 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +77% but shares only +4% — price-driven

Value
+77%
Shares
+3%
Last quarter: the total dollar value of institutional holdings rose +77%, but actual share count only changed +4%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

54 → 48 → 56 → 62 → 102 new funds/Q
New funds entering each quarter: 48 → 56 → 62 → 102. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 42% of holders stayed 2+ years

■ 42% veterans ■ 18% 1-2yr ■ 39% new
Of 384 current holders: 163 (42%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 37% AUM from major funds

37% from top-100 AUM funds
42 of 368 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RVMD

In 2025 Q4, 231 hedge funds were net buyers of RVMD (102 opened a new position, 129 added to an existing one), while 145 reduced or exited (105 trimmed, 40 sold completely) — a 61% buyer ratio, indicating clear institutional accumulation. This marks 10 consecutive quarters of net institutional buying — a persistent conviction signal. 37% of total institutional value in RVMD is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +62 funds (more new holders than closures). Total institutional holders: 368.

Hedge Fund Ownership: RVMD

How many hedge funds hold RVMD — quarterly history vs. share price
Quarterly hedge fund ownership of RVMD vs. share price

Market Analysis: RVMD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RVMD

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

59 top-rated funds 17 high-conviction
Consensus
7.7
/ 10
breadth
×
Elite
5.3
/ 10
conviction
Hedge Fund Positioning: RVMD
2026 Q1 Stats Unlock in 8 days 384 + Investors

Track Smart Money conviction in RVMD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 384 323 18.89%
13F Shares 202M 195M 3.6%
Total Value $15.78B $8.90B 77.36%
New Positions 103 62 +41
Increased Positions 148 143 +5
Closed Positions 42 47 -5
Reduced Positions 122 107 +15
Total Calls 10 10 -
Total Puts 8 8 -
PUT/CALL Ratio 0.8 0.8 Neutral

Statistics: RVMD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

384 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RVMD. Verified SEC 13F-HR filings.

Top 25 institutional holders of RVMD — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 AIHC Capital Management Ltd 67.37% 828,974 $80.6M
2 Lunate Capital Ltd 44.36% 549,050 $53.4M
3 Alphabet Inc. 7.97% 3,292,525 $320.2M
4 Mass General Brigham, Inc 7.14% 344,091 $33.5M
5 Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 3.95% 479,080 $46.6M
6 Atle Fund Management AB 2.93% 617,245 $9.1M
7 Melqart Asset Management (UK) Ltd 2.59% 270,363 $26.3M
8 Cannon Global Investment Management, LLC 1.61% 8,500 $827K
9 Catalyst Funds Management Pty Ltd 1.09% 66,261 $6.4M
10 Persistent Asset Partners Ltd 0.94% 26,043 $2.5M
11 a16z Perennial Management, L.P. 0.84% 104,214 $10.1M
12 Sandy Cove Advisors, LLC 0.79% 27,008 $2.6M
13 SUMMIT SECURITIES GROUP LLC 0.67% 55,700 $5.4M
14 TEMA ETFS LLC 0.64% 98,178 $9.5M
15 WESTFIELD CAPITAL MANAGEMENT CO LP 0.64% 1,556,578 $151.4M
16 GENERAL AMERICAN INVESTORS CO INC 0.40% 62,545 $6.1M
17 Candriam S.C.A. 0.29% 580,677 $56.5M
18 China Universal Asset Management Co., Ltd. 0.26% 35,167 $3.4M
19 Park Avenue Institutional Advisers LLC 0.25% 5,115 $497K
20 Bayforest Capital Ltd 0.21% 1,905 $185K
21 S&CO INC 0.21% 34,171 $3K
22 Covestor Ltd 0.19% 2,840 —
23 WEST MICHIGAN ADVISORS, LLC 0.18% 8,218 $799K
24 Wedmont Private Capital 0.13% 40,231 $3.9M
25 Abel Hall, LLC 0.12% 5,842 $568K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — REVOLUTION MEDICINES INC (RVMD)

What does the Smart Money Trend signal show for RVMD?

Buying streak — 10 quarters in a row: For 10 consecutive quarters, more hedge funds added RVMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RVMD?

More buyers than sellers — 61% buying: Last quarter: 231 funds were net buyers (102 opened a brand new position + 129 added to an existing one). Only 145 were sellers (105 trimmed + 40 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for RVMD holders?

Strong quality — 37% AUM from major funds: 42 of 368 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held RVMD?

Mixed — 37% long-term, 33% new: Of the 368 current holders: 136 (37%) held >2 years, 111 held 1–2 years, and 121 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.